1-6 of 6
Tiffany T. Khong, PhD
Close
Sort by
Journal Articles

A 2-Stage Phase II Study of Panobinostat Consolidation in Multiple Myeloma (MM) Patients with < CR Following Single High-Dose Chemotherapy (HDT) Conditioned Autologous Stem Cell Transplantation (ASCT) As Part of First Line Therapy

Anna Kalff, MBBS, FRACP, FRCPA, Sridurga Mithraprabhu, PhD, Tiffany T. Khong, PhD, Malarmathy Ramachandran, Kate Reed, Hang Quach, MBBS (Hons), FRACP, FRCPA, MD, Patricia A. Walker, MBBS, FRACP, FRCPA, Krystal Bergin, Andrew Spencer
Journal: Blood
Blood (2016) 128 (22): 4515.
https://doi.org/10.1182/blood.V128.22.4515.4515
Published: 2016
Journal Articles

Overcoming Innate Resistance to a Beta-Catenin Inhibitor-BC2059- By Manipulating Autophagy in Multiple Myeloma

Ioanna Savvidou, MDPhD, Tiffany T. Khong, PhD, Stephen K. Horrigan, PhD, Andrew Spencer
Journal: Blood
Blood (2016) 128 (22): 5669.
https://doi.org/10.1182/blood.V128.22.5669.5669
Published: 2016
Journal Articles

Roar: A Phase Ib Trial of Oral Azacitidine (CC-486) in Combination with Lenalidomide and Dexamethasone (Rd) for Patients with Relapsed and/or Refractory (R/R) Multiple Myeloma Who Have Failed a Prior Lenalidomide-Containing Regimen

Anna Kalff, MBBS, FRACP, FRCPA, Kate Reed, Tiffany T. Khong, PhD, Sridurga Mithraprabhu, PhD, Malarmathy Ramachandran, John Reynolds, Krystal Bergin, Anjan Thakurta, PhD, Maria Wang, PhD, Andrew Spencer, Roberto Guzman, Suzana Cuoto, Yan Ren, MD
Journal: Blood
Blood (2016) 128 (22): 2121.
https://doi.org/10.1182/blood.V128.22.2121.2121
Published: 2016
Journal Articles

In Vitro and In Vivo Efficacy of a Novel Orally Bioavailable Beta-Catenin Inhibitor-BC2059- As Monotherapy or in Combination with Proteasome Inhibitors in Multiple Myeloma

Ioanna Savvidou, MD PhDstudent, Tiffany T. Khong, PhD, Stephen K. Horrigan, PhD, Andrew Spencer
Journal: Blood
Blood (2015) 126 (23): 1816.
https://doi.org/10.1182/blood.V126.23.1816.1816
Published: 2015
Journal Articles

Evaluation of Circulating Tumour DNA for the Mutational Characterisation of Multiple Myeloma

Andrew Spencer, Sridurga Mithraprabhu, Post doc, Malarmathy Ramachandran, Daniela Klarica, RN, Jay Hocking, MD, Laura Mai, Stephanie Walsh, David Broemeling, Andre Marziali, Anna Kalff, MD, Matthew Wiggin, Brian G. M. Durie, MD, Tiffany T. Khong, PhD
Journal: Blood
Blood (2015) 126 (23): 368.
https://doi.org/10.1182/blood.V126.23.368.368
Published: 2015
Journal Articles

Roar: A Phase Ib Trial of Oral Azacitidine in Combination with Lenalidomide and Dexamethasone for Relapsed Multiple Myeloma (MM) Patients Refractory to Prior Lenalidomide

Anna Kalff, MD, Kate Reed, Tiffany T. Khong, PhD, Sridurga Mithraprabhu, Post doc, Malarmathy Ramachandran, Richard Hall, Krystal Bergin, MBBS, Andrew Spencer
Journal: Blood
Blood (2015) 126 (23): 3033.
https://doi.org/10.1182/blood.V126.23.3033.3033
Published: 2015